Nucleoside analogs: ready to enter the era of precision medicine? - Wikidata - awgldk - TriplyDB

Nucleoside analogs: ready to enter the era of precision medicine?

Nucleoside analogs: ready to enter the era of precision medicine?

http://www.wikidata.org/entity/Q38842938

about

Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism

P2860

Q57175017-1DC0721D-EB1A-4963-9F56-911F4ABE2305

P2860

Nucleoside analogs: ready to enter the era of precision medicine?

http://www.wikidata.org/entity/Q38842938

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Nucleoside analogs: ready to enter the era of precision medicine?

@en

type

label

Nucleoside analogs: ready to enter the era of precision medicine?

@en

prefLabel

Nucleoside analogs: ready to enter the era of precision medicine?

@en

P1433

Q38842938-E77CCD62-833A-4657-B548-D0117A04BF92

P1476

Q38842938-98BEB568-6038-4539-B1CB-08B41C85DE08

P2093

Q38842938-067EEF19-C893-4555-AED9-13816A3175E2

Q38842938-2ABA56D6-77BD-4AE4-BB85-F70DDF9A7BA0

Q38842938-65C259C2-CF8E-4DA2-825E-61A568FE11CD

Q38842938-7BDBCB8C-7B85-457D-9844-058F301BA038

Q38842938-8B733383-CAA3-4E52-A7B0-BF52F1017F07

Q38842938-F21A933C-40EE-4B58-8DBD-A58490D0718B

P2860

Q38842938-0086FA23-FD31-4079-9214-C6C721E99022

Q38842938-02E3E7BA-F0EC-48BB-BF4F-0276B16AB807

Q38842938-05E5EB4F-D583-4080-B212-2FA841CD3549

Q38842938-065215A6-2DBB-4715-9C77-E68918CCC193

Q38842938-089D51A3-ECBC-4628-B6CA-5AD0EF5BA806

Q38842938-098852FD-CDBD-4518-A094-7AF6925AD49C

Q38842938-0CDFE014-06B9-4385-892B-C22B1336849F

Q38842938-0EAFD0D0-1B81-4E89-A9A3-8300BD96F08F

Q38842938-108B63EB-00C4-47D7-AFD7-B13F929EC046

Q38842938-14243ABA-5F48-42D7-BFCA-DE8F10939946

P304

Q38842938-A6A7C778-BC30-4015-B4F8-7A7B2DE2FA06

P31

Q38842938-E457316C-5F75-426B-84BA-9FBC06B29AD3

Q38842938-f727cd08-8230-4616-bc64-265d50877b31

P356

Q38842938-D6812163-EA63-45BD-84B6-19DD26501EAC

P407

Q38842938-E53343C2-F678-4C29-AAB8-8077731156BF

P433

Q38842938-0175D742-C134-45CD-9AAE-A42F265530E8

P478

Q38842938-B2B8C421-510A-4C05-BCA4-84F4F4A681C4

P577

Q38842938-D2510AA7-76E5-4FB6-84AE-47471ADD3C29

P698

Q38842938-A9B3E3F2-7C36-433E-BF04-2E5086A43C06

P356

17425255.2016.1192128

P1433

Expert Opinion on Drug Metabolism & Toxicology

P1476

Nucleoside analogs: ready to enter the era of precision medicine?

@en

P2093

Bruno Lacarelle

http://www.w3.org/2001/XMLSchema#string

Cindy Serdjebi

http://www.w3.org/2001/XMLSchema#string

Gerard Milano

http://www.w3.org/2001/XMLSchema#string

Hau Le Thi Thu

http://www.w3.org/2001/XMLSchema#string

Joseph Ciccolini

http://www.w3.org/2001/XMLSchema#string

Raphaelle Fanciullino

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer pharmacogenomics: strategies and challenges

hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: a systematic review

Early phase clinical trials to identify optimal dosing and safety

Covariate pharmacokinetic model building in oncology and its potential clinical relevance.

Oral Azacitidine (CC-486) for the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia

Expression of deoxycytidine kinase in leukaemic cells compared with solid tumour cell lines, liver metastases and normal liver

Severe or lethal toxicities upon capecitabine intake: is DPYD genetic polymorphism the ideal culprit?

A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil

Strong association of a common dihydropyrimidine dehydrogenase gene polymorphism with fluoropyrimidine-related toxicity in cancer patients

FFCD-1004 Clinical Trial: Impact of Cytidine Deaminase Activity on Clinical Outcome in Gemcitabine-Monotherapy Treated Patients

P304

865-877

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17425255.2016.1192128

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27218825

http://www.w3.org/2001/XMLSchema#string